Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering
New York, July 31, 2014 (Global Newswire) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Intellect Neurosciences, Inc. (ILNS: OTC US) on a $1.2 million private placement consisting of Series F Preferred Stock and Warrants. Intellect Neurosciences Inc. is a biopharmaceutical company engaged in the discovery and development of disease modifying therapeutic agents for the treatment and prevention of Alzheimer’s disease. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019